In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Consort Medical PLC

www.consortmedical.com

Latest From Consort Medical PLC

MTI Top 100: Leading Medtechs See Steady Organic Growth In A Market On The Cusp Of Change

The disruptive medtech M&A of recent years was not matched in the past year for volume, but there were isolated outbreaks of major activity, as shown in our company rankings. 

International Commercial

Recipharm Boosts Inhalation And Injectables Manufacturing By Acquiring UK’s Consort Medical

Sweden's Recipharm has agreed to buy UK-based Consort Medical for £505m ($652m) to become a leading inhalation-device company. 

Deals Manufacturing

Factory Explosion Expected To Cost Consort Millions In Profit

Consort Medical issued a profit warning following a factory explosion. The company said the incident is likely to cut between £3-5m from its annual profits.

Manufacturing Commercial

Major M&A Bookends Year Of Mainly Steady Growth For Leading Medtech Groups

Scrip's latest rankings of the top 100 revenue earners in the medical technology industry, published in Outlook 2019, show the groups leading the global market tightening their grip further in 2017. This was partly a function of providers choosing to partner more and more with fewer suppliers who can offer a wider provision of services. But it was steady as she goes for most of the multinational medtechs, with some major exceptions, and there will be more M&A reflected in next year's rankings, based on 2018 revenues.

Outlook 2019 Market Intelligence
See All

Company Information

  • Industry
  • Contract Research, Toxicology Testing-CRO
  • In Vitro Diagnostics
  • Pharmaceuticals
    • Drug Delivery
      • Nasal
      • Pulmonary
  • Services
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Bespak PLC
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • UK
  • Parent & Subsidiaries
  • Consort Medical PLC
  • Senior Management
  • Jonathan Glenn, CEO
    Paul Hayes, CFO
  • Contact Info
  • Consort Medical PLC
    Phone: (44) 01442 867920
    Breakspear Pk., Breakspear Way
    Ste. D
    Hemel Hempstead , HP2 4TZ
    UK
UsernamePublicRestriction

Register